- Drugs
- Friday, 05 Jun 2020
Ionis Pharmaceuticals to present at upcoming virtual investor conferences
Ionis Pharmaceuticals, Inc., an antisense therapeutics company, announced that management will present a company overview at the following virtual investor conferences:
- William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, 2020;
- Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020; and
- BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020.
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.ionispharma.com for the latest information.
A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.
Related Industry Updates
Small Cell Lung Cancer (SCLC) Treatment Market is expected to reach US$ 9,173.60 million by 2030
Dec 21, 2023
Global Recall of the Common Heartburning Drugs Over the Risk of Cancer
Jan 21, 2020
Asia Pacific Companion Animal Diagnostics Market Research Along With COVID-19 Impact Analysis, Advancement and Outlook 2027| Fujifilm Corporation, Skyla Corporation, Virbac
Jan 15, 2021
Europe Pharmaceutical Continuous Manufacturing Market 2027 Growth Factors, Opportunities, Ongoing Trends with Top Companies Like Fette Compacting, KORSCH AG, LEISTRITZ AG, ALEXANDERWERK AG, Hovione
Dec 02, 2020
Christopher Hite Joins Royalty Pharma
Feb 28, 2020
North America Drug Modelling Software Market Emerging Trends and Prospects 2027 With Leading Players are Chemical Computing Group ULC, Nimbus Therapeutics, Schrödinger, Inc
Dec 30, 2020
Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 20, 2020
Follow us on
